Home Data Calendar Blog

CARA

Tables

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Common Stock Value 0.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.040.040.040.040.030.030.030.030.030.030.030.030.030.030.030.020.020.020.020.020.020.00NANA
Weighted Average Number Of Diluted Shares Outstanding 54.8454.7254.59NA54.2454.0053.87NA53.7353.6153.51NA50.1150.0649.92NA46.8946.8046.72NA44.5239.8239.55NA38.0333.32NA32.5932.2427.30NA27.2827.2827.26NA25.5522.8322.81NA22.7122.6115.65NA4.2915.97
Weighted Average Number Of Shares Outstanding Basic 54.8454.7254.59NA54.2454.0053.87NA53.7353.6153.51NA50.1150.0649.92NA46.8946.8046.72NA44.5239.8239.55NA38.0333.32NA32.5932.2427.30NA27.2827.2827.26NA25.5522.8322.81NA22.7122.6115.65NA4.294.29
Earnings Per Share Basic -0.23-0.37-0.56-0.60-0.52-0.58-0.49-0.56-0.43-0.08-0.52-0.64-0.02-0.61-0.471.60-0.35-0.54-0.62NANANANANANANANANANANANANANANANANANANANANA-0.16NA-0.49-1.070.34
Earnings Per Share Diluted -0.23-0.37-0.56-0.60-0.52-0.58-0.49-0.56-0.43-0.08-0.52-0.64-0.02-0.61-0.471.59-0.35-0.54-0.62NANANANANANANANANANANANANANANANANANANANANA-0.16NA-0.49-1.070.33

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Revenue From Contract With Customer Excluding Assessed Tax 2.560.992.133.004.876.936.173.2610.8123.004.790.8220.270.001.94112.099.275.638.094.515.795.214.385.535.062.870.000.000.000.910.000.000.080.010.002.440.870.490.911.120.960.180.971.029.97
Revenues 2.560.992.133.004.876.936.173.2610.8123.004.790.8220.270.001.94112.099.275.638.094.515.795.214.385.535.062.870.000.000.000.910.000.000.080.010.002.440.870.490.911.120.960.180.971.029.97
Operating Expenses 8.5418.3031.8035.6133.7639.2733.8134.5734.6627.4832.7034.3421.4030.8825.5033.8026.2931.5238.0934.4840.2229.3527.5227.5125.5320.6914.5712.969.6323.2422.3211.7713.4010.999.737.456.615.215.257.734.673.603.084.563.05
Research And Development Expense 1.369.3121.9628.4125.4530.3124.3326.0124.6919.9121.2722.8315.5125.2319.1327.1421.0726.1133.5429.8635.9924.3623.6122.8022.3017.0011.589.156.9620.8420.289.6710.768.557.575.584.683.383.466.213.202.201.983.762.02
General And Administrative Expense 6.476.416.826.596.757.546.896.436.917.579.3511.515.885.656.376.665.225.414.564.624.234.993.914.713.233.693.003.812.672.402.042.102.652.452.161.861.921.821.791.521.471.401.100.801.03
Operating Income Loss -5.99-17.31-29.67-32.61-28.90-32.34-27.65-31.31-23.84-4.47-27.91-33.52-1.12-30.88-23.5678.29-17.02-25.88-30.00-29.97-34.43-24.14-23.13-21.98-20.47-17.81-14.57-12.96-9.63-22.32-22.32-11.77-13.33-10.99-9.73-5.01-5.73-4.72-4.34-6.60-3.71-3.42-2.10-3.546.92
Profit Loss -12.48-20.02-30.70-32.34-28.03-31.48-26.66-30.34-23.18-4.21-27.75-33.38-1.01-30.75-23.3078.91-16.51-25.07-28.92-28.61-32.84-22.96-21.96-20.65-19.40-17.19-14.18NANANANANANANANANANANANANANANANANANA
Other Comprehensive Income Loss Net Of Tax 0.100.070.07NA0.290.370.57NA-0.10-0.32-1.36NA0.01-0.02-0.06-0.29-0.270.70-0.240.02-0.010.090.19-0.130.070.06-0.110.05-0.040.02-0.02-0.020.040.04NANANANANANANANANANANA
Net Income Loss -12.48-20.02-30.70-32.34-28.03-31.48-26.66-30.34-23.18-4.21-27.75-33.38-1.01-30.75-23.3078.91-16.51-25.07-28.92-28.61-32.84-22.96-21.96-20.65-19.40-17.19-14.18-12.44-9.30-22.20-21.97-11.54-13.07-10.69-9.53-4.79-5.68-4.69-4.17-6.54-3.65-3.38-2.09-4.585.34
Comprehensive Income Net Of Tax -12.38-19.95-30.63-32.16-27.74-31.11-26.09-29.86-23.28-4.53-29.11-33.74-1.01-30.76-23.3678.62-16.78-24.36-29.16-28.59-32.85-22.87-21.77-20.78-19.33-17.14-14.29-12.39-9.34-22.18-21.99-11.56-13.04-10.65-9.56-4.79-5.68-4.69NANANANANANANA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Assets 51.3372.5090.10125.84115.34134.39153.28182.24213.51226.57223.87247.06225.09221.45250.23271.16147.14168.61196.17232.96263.80149.64170.59190.82212.70139.8997.00108.05117.9743.3063.8380.1592.05102.01110.90117.9046.4451.6555.9362.3768.1971.5618.08NANA
Liabilities 50.6260.9060.3068.76NANANA23.46NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Liabilities And Stockholders Equity 51.3372.5090.10125.84115.34134.39153.28182.24213.51226.57223.87247.06225.09221.45250.23271.16147.14168.61196.17232.96263.80149.64170.59190.82212.70139.8997.00108.05117.9743.3063.8380.1592.05102.01110.90117.9046.4451.6555.93NANANANANANA
Stockholders Equity 0.7111.6029.8057.0985.64108.93136.60158.78184.82204.42204.12227.52207.19203.47230.46249.00127.85140.93160.47186.71211.8999.55114.52133.63149.5373.0886.7899.07109.2229.2750.7371.8082.5994.93105.04113.8642.4747.4251.6655.3461.5764.73-54.08-51.99-48.43

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Assets Current 47.9163.8681.22116.16100.60124.74142.66168.91186.78176.17151.76173.29171.50164.47188.35195.06132.84141.91132.67165.66203.46124.77144.16168.14211.39138.5395.06105.98115.8141.0361.4577.0289.1499.47108.93115.6844.0349.0653.1559.4165.0668.2314.56NANA
Cash And Cash Equivalents At Carrying Value 37.0649.2447.0051.7762.8858.2547.3963.7442.8146.7221.3613.4522.9922.3422.5231.6875.2856.9717.0418.3034.7018.4914.1915.0896.7317.809.3911.799.425.3112.095.433.547.9215.10111.1243.1947.4252.6658.3962.8167.0412.3617.7321.18
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 38.5650.7448.5053.6864.7860.1647.8064.1543.2147.1321.7713.8623.4022.7422.9332.0975.6957.3817.4418.7135.1119.2614.9615.8597.5018.5710.1613.2610.886.7813.56NANANA15.80NANANANANANANANANANA
Accounts Receivable Net Current 0.430.361.722.773.35NANA3.26NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Inventory Net 0.621.642.742.823.273.423.522.381.833.461.912.58NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Property Plant And Equipment Net 3.423.493.553.321.380.310.370.430.490.550.610.630.650.720.780.840.730.600.650.700.750.800.840.880.910.961.181.301.401.501.611.671.431.071.261.521.711.902.082.262.442.632.83NANA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Liabilities Current 10.0413.9015.1025.5922.8825.4616.6823.4628.1921.1718.3017.6215.5315.1716.5218.4816.6024.7332.6042.8948.3040.1642.4140.4543.2434.828.517.277.1912.5111.536.838.176.095.273.373.243.433.406.095.625.755.43NANA
Accounts Payable Current 2.546.754.9811.587.9812.124.429.6015.229.745.595.625.373.394.764.896.484.839.319.109.542.484.944.372.643.693.831.191.861.694.742.392.932.351.971.260.710.940.521.721.191.590.68NANA
Accounts Payable And Accrued Liabilities Current 6.6213.7314.8825.5922.3824.4815.2221.5426.3219.3316.5015.8613.8113.4914.8816.8815.0613.9517.3719.6620.5812.7713.3113.6214.0012.558.517.277.1912.5111.536.838.176.095.273.373.152.461.954.152.552.341.96NANA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Stockholders Equity 0.7111.6029.8057.0985.64108.93136.60158.78184.82204.42204.12227.52207.19203.47230.46249.00127.85140.93160.47186.71211.8999.55114.52133.63149.5373.0886.7899.07109.2229.2750.7371.8082.5994.93105.04113.8642.4747.4251.6655.3461.5764.73-54.08-51.99-48.43
Common Stock Value 0.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.050.040.040.040.040.030.030.030.030.030.030.030.030.030.030.030.020.020.020.020.020.020.00NANA
Additional Paid In Capital Common Stock 748.61747.12745.38742.04738.43733.98730.54726.63722.81719.13714.29708.59699.48649.78646.01641.20598.66594.96590.14587.22583.81438.61430.72428.06423.18327.40307.16305.17302.92300.15212.87211.95211.18210.48209.94209.20133.02132.29131.84NANANA8.38NANA
Retained Earnings Accumulated Deficit -747.93-735.46-715.44-684.75-652.41-624.38-592.90-566.23-535.89-512.71-508.51-480.76-447.38-446.36-415.62-392.32-471.23-454.72-429.65-400.73-372.12-339.27-316.31-294.35-273.70-254.30-220.34-206.16-193.72-184.42-162.17-140.20-128.66-115.58-104.89-95.36-90.57-84.89-80.20-76.03-69.48-65.84-62.46NANA
Accumulated Other Comprehensive Income Loss Net Of Tax -0.03-0.12-0.19-0.26-0.44-0.73-1.10-1.67-2.15-2.05-1.72-0.360.00-0.010.010.070.360.64-0.070.170.150.170.07-0.110.01-0.06-0.070.04-0.010.020.000.020.040.00-0.04NANANA0.00NANANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1.341.511.66NA3.173.122.97NA3.524.234.27NA3.493.382.74NA3.312.992.85NA2.832.682.232.031.822.071.751.621.321.110.830.780.700.500.710.660.700.450.340.220.460.350.010.06NA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Net Cash Provided By Used In Operating Activities -13.98-12.44-30.45-17.37-19.64-20.45-34.62-23.51-25.19-4.50-25.52-1.25-14.12-21.00-23.7282.09-21.62-27.65-38.30-31.17-25.64-24.90-27.53-24.36-20.4941.02-11.41-9.85NANANANANANANANANANANANANANANANANA
Net Cash Provided By Used In Investing Activities 2.5015.2925.95-30.2023.1632.8017.7144.4221.1829.6833.43-53.5814.4320.5313.87-164.1639.5467.3836.9614.74-96.8825.2326.40-57.835.45-51.148.1312.08NANANANANANANANANANANANANANANANANA
Net Cash Provided By Used In Financing Activities -0.69-0.61-0.6936.481.120.000.560.020.100.180.0045.290.340.290.6938.470.400.200.070.03138.373.970.230.5493.9716.040.180.15NANANANANANANANANANANANANANANANANA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Net Cash Provided By Used In Operating Activities -13.98-12.44-30.45-17.37-19.64-20.45-34.62-23.51-25.19-4.50-25.52-1.25-14.12-21.00-23.7282.09-21.62-27.65-38.30-31.17-25.64-24.90-27.53-24.36-20.4941.02-11.41-9.85NANANANANANANANANANANANANANANANANA
Net Income Loss -12.48-20.02-30.70-32.34-28.03-31.48-26.66-30.34-23.18-4.21-27.75-33.38-1.01-30.75-23.3078.91-16.51-25.07-28.92-28.61-32.84-22.96-21.96-20.65-19.40-17.19-14.18-12.44-9.30-22.20-21.97-11.54-13.07-10.69-9.53-4.79-5.68-4.69-4.17-6.54-3.65-3.38-2.09-4.585.34
Profit Loss -12.48-20.02-30.70-32.34-28.03-31.48-26.66-30.34-23.18-4.21-27.75-33.38-1.01-30.75-23.3078.91-16.51-25.07-28.92-28.61-32.84-22.96-21.96-20.65-19.40-17.19-14.18NANANANANANANANANANANANANANANANANANA
Depreciation Depletion And Amortization 0.070.080.040.080.060.060.060.060.060.060.060.060.060.060.060.060.050.050.050.050.050.050.050.050.080.110.120.120.120.120.120.100.520.730.260.190.190.190.190.200.200.200.200.200.20
Increase Decrease In Inventories 0.000.39-0.08-0.45-0.15-0.101.130.55-1.621.55-0.68NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Share Based Compensation 1.491.743.353.603.333.443.353.803.574.665.708.784.393.484.134.073.314.622.853.392.934.012.233.721.822.071.751.621.321.110.830.780.700.500.710.660.700.450.340.221.16-0.350.010.060.06

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Net Cash Provided By Used In Investing Activities 2.5015.2925.95-30.2023.1632.8017.7144.4221.1829.6833.43-53.5814.4320.5313.87-164.1639.5467.3836.9614.74-96.8825.2326.40-57.835.45-51.148.1312.08NANANANANANANANANANANANANANANANANA
Payments To Acquire Property Plant And Equipment 0.000.210.842.05NANANA0.000.000.000.04NANANANA0.17NANANA0.000.000.010.010.020.030.020.000.030.020.010.070.490.150.010.010.000.010.010.010.02NANA0.00NANA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Net Cash Provided By Used In Financing Activities -0.69-0.61-0.6936.481.120.000.560.020.100.180.0045.290.340.290.6938.470.400.200.070.03138.373.970.230.5493.9716.040.180.15NANANANANANANANANANANANANANANANANA

    2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Revenues 2.560.992.133.004.876.936.173.2610.8123.004.790.8220.270.001.94112.099.275.638.094.515.795.214.385.535.062.870.000.000.000.910.000.000.080.010.002.440.870.490.911.120.960.180.971.029.97
Csl Vifor, Commercial Supply Revenue, 0.000.000.640.001.251.403.192.063.37NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Csl Vifor, Other Non Cash Revenue, 0.430.360.29NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Excluding Assessed Tax 2.560.992.133.004.876.936.173.2610.8123.004.790.8220.270.001.94112.099.275.638.094.515.795.214.385.535.062.870.000.000.000.910.000.000.080.010.002.440.870.490.911.120.960.180.971.029.97
Csl Vifor, Collaborative Revenue,, Csl Vifor Profit Sharing 1.300.000.792.311.935.412.751.137.44NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Csl Vifor, Commercial Supply Revenue,, Csl Vifor Korsuva 0.000.000.64NA1.251.403.19NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Csl Vifor, Other Revenue Non Cash,, Csl Vifor Kapruvia 0.430.360.29NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Clinical Compound Revenue 0.000.000.080.000.070.000.10NANANANA0.120.240.000.040.030.010.540.070.000.000.000.140.000.03NA0.000.00NANANANANANANANANANANANANANANANANA
Collaborative Revenue 1.300.000.792.312.475.412.751.137.448.00NA0.000.000.000.71NANANANANANANANANANANA0.000.00NANANANANANANANANANANANANANANANANA
Commercial Supply Revenue 0.000.000.640.001.251.403.192.063.370.004.79NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Revenue 1.260.990.62NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Revenue Non Cash 1.260.990.62NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Clinical Compound Revenue, License Agreement With Maruishi Pharmaceutical Company Limited 0.000.000.080.000.070.000.10NANANANA0.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Revenue Non Cash, License Agreement With Maruishi Pharmaceutical Company Limited 0.820.630.33NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Net Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Stockholders Equity
Assets
Inventory Net
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Property Plant And Equipment Net
Liabilities
Liabilities Current
Current Liabilities
Accounts Payable Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding

Line plots across dimensions of each concept